Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-04

Clinical Trial Update: Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether probiotics affect the fecal resistome during Helicobacter pylori eradication therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: Universidad San Francisco de Quito | Conditions: Gut Resistome | Phase 4 | Status: COMPLETED